AI speeds up drug design for Parkinson’s ten-fold
17 April 2024Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.
Scientists have made a ‘vital step’ towards understanding the origins of Parkinson’s disease – the fastest growing neurological condition in the world.
Study shows how to determine the elusive motions of proteins that remain disordered.
A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer’s disease, which was previously thought to be undruggable.
Researchers have found a way to design an antibody that can identify the toxic particles that destroy healthy brain cells – a potential advance in the fight against Alzheimer’s disease.
Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease.
The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge.
Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and progression of Alzheimer’s disease.
“I was taught that the way of progress is neither swift nor easy”.
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production.